Trade ALLR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Allarity Therapeutics, Inc. (ALLR) is trading at US$1.22, down 2.40% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$22.59M. Over the past 52 weeks, ALLR has traded between US$0.77 and US$1.84. On Syfe you can trade ALLR with $0 commission and add it to your watchlist.
| Previous close | US$1.25 |
|---|---|
| Market cap | US$22.59M |
| 52-week range | US$0.77 – US$1.84 |
| Volume | 193.48K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments. The company is focused on development of stenoparib, a novel PARP and tankyrase inhibitor for advanced ovarian cancer patients, using its DRP technology to develop a companion diagnostic that can be used to select those patients expected to derive the greatest clinical benefit from stenoparib. Allarity Therapeutics was founded by Steen Knudsen and Thomas H. Jensen in 2004 and is headquartered in Tarpon Springs, FL.
Year: 2021
Allarity Therapeutics Obtains Registration Certificate for Laboratory
Jul 7, 12:49 PM · MT Newswires
Allarity Therapeutics, Inc. (ALLR) stock is trading at US$1.22, -2.40% from the previous close of US$1.25.
The market cap for Allarity Therapeutics, Inc. (ALLR) stock is approximately US$22.59M.
The 52-week high for Allarity Therapeutics, Inc. (ALLR) stock is US$1.84.
The 52-week low for Allarity Therapeutics, Inc. (ALLR) stock is US$0.77.
Allarity Therapeutics, Inc. (ALLR) does not currently pay a dividend.
Stay on top of ALLR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
